LU87033A1 - Nouvelle association medicamenteuse - Google Patents

Nouvelle association medicamenteuse Download PDF

Info

Publication number
LU87033A1
LU87033A1 LU87033A LU87033A LU87033A1 LU 87033 A1 LU87033 A1 LU 87033A1 LU 87033 A LU87033 A LU 87033A LU 87033 A LU87033 A LU 87033A LU 87033 A1 LU87033 A1 LU 87033A1
Authority
LU
Luxembourg
Prior art keywords
tizanidine
ibuprofen
composition according
pharmaceutically acceptable
treatment
Prior art date
Application number
LU87033A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87033A1 publication Critical patent/LU87033A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU87033A 1986-11-03 1987-10-30 Nouvelle association medicamenteuse LU87033A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3637240 1986-11-03
DE3637240 1986-11-03

Publications (1)

Publication Number Publication Date
LU87033A1 true LU87033A1 (fr) 1988-05-03

Family

ID=6312966

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87033A LU87033A1 (fr) 1986-11-03 1987-10-30 Nouvelle association medicamenteuse

Country Status (18)

Country Link
JP (1) JPS63132834A (da)
KR (1) KR890007728A (da)
AU (1) AU8057587A (da)
BE (1) BE1000265A3 (da)
DD (1) DD300508A5 (da)
DK (1) DK574187A (da)
FR (1) FR2605884B1 (da)
GB (1) GB2197198A (da)
GR (1) GR871678B (da)
HU (1) HUT47849A (da)
IL (1) IL84344A0 (da)
IT (1) IT8748554A0 (da)
LU (1) LU87033A1 (da)
NL (1) NL8702523A (da)
PH (1) PH23276A (da)
PT (1) PT86061B (da)
SE (1) SE8704240L (da)
ZA (1) ZA878257B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
US20040122065A1 (en) * 2002-11-12 2004-06-24 Lerner E. Itzhak Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally
TR200703092A1 (tr) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen ve kas gevşetici kombinasyonları
AU2013252491A1 (en) * 2012-04-27 2014-11-06 Troy Laboratories Pty Ltd Combination meloxicam and xylazine therapy in animals
WO2016012398A1 (en) 2014-07-21 2016-01-28 Sanovel Ilac Sanayi Ve Ticaret A.S. Zaltoprofen and muscle relaxant combinations
EP3197434A1 (en) 2014-09-24 2017-08-02 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012837A1 (de) * 1979-04-10 1980-10-30 Sandoz Ag Analgetische und myotonolytische praeparate
GB2135884B (en) * 1983-03-09 1986-09-17 Sandoz Ltd Analgesic preparations containing tizanidine and paracetamol
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method

Also Published As

Publication number Publication date
FR2605884A1 (fr) 1988-05-06
PT86061A (en) 1987-12-01
KR890007728A (ko) 1989-07-05
HUT47849A (en) 1989-04-28
IL84344A0 (en) 1988-04-29
BE1000265A3 (fr) 1988-09-27
NL8702523A (nl) 1988-06-01
DK574187A (da) 1988-05-04
GB8725538D0 (en) 1987-12-02
FR2605884B1 (fr) 1989-05-05
DK574187D0 (da) 1987-11-02
SE8704240L (sv) 1988-05-04
GB2197198A (en) 1988-05-18
PT86061B (pt) 1990-11-07
IT8748554A0 (it) 1987-10-30
AU8057587A (en) 1988-05-05
SE8704240D0 (sv) 1987-10-30
PH23276A (en) 1989-06-23
JPS63132834A (ja) 1988-06-04
GR871678B (en) 1988-03-03
DD300508A5 (de) 1992-06-17
ZA878257B (en) 1989-06-28

Similar Documents

Publication Publication Date Title
EP1795194A2 (fr) Utilisation d'un antagoniste des récepteurs CB1 associé à un bêta3-agoniste pour la préparation de médicaments utiles pour traiter l'appétence
US6147108A (en) Method for treating type II diabetes mellitus
BE897355A (fr) Compositions analgestiques et anti-inflammatoires comprenant de l'ibuprofen
WO1997015304A1 (fr) Utilisation de la 1-(2-napht-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique
FR2904774A1 (fr) Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent.
BE1000265A3 (fr) Nouvelle association medicamenteuse.
FR2837706A1 (fr) Utilisation d'un antagoniste des recepteurs aux cannabinoides cb1 pour la preparation de medicaments utiles pour traiter les dysfonctionnements sexuels et/ou ameliorer les performances sexuelles
BE1007024A5 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1, selective.
EP1441723B1 (fr) Utilisation de l'irbesartan pour la prevention ou le traitement de l'hypertension pulmonaire
LU85242A1 (fr) Nouvelle association medicamenteuse
EP0966276B1 (fr) Utilisation d'agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
CA1059913A (fr) Compositions pharmaceutiques
EP1115399B1 (fr) Utilisation d'une composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et l'indomethacine pour la fabrication d'un medicament pour traiter les glomerulonephrites chroniques
US20010056115A1 (en) Novel therapeutic method
BE1007586A3 (fr) Produits pharmaceutiques.
JPH0680009B2 (ja) 抗高血圧組み合わせ医薬
CA2684171C (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
CA1079195A (fr) Procede de preparation d'un nouveau medicament hypotenseur a action retardee
FR2551974A1 (fr) Preparation de dobutamine pour l'administration orale
CA2597245A1 (fr) Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2
JPS5942318A (ja) 製薬組成物、その製造法及び応用
CA1227136A (fr) Compositions pharmaceutiques contenant a titre de principe actif l'acide 4-(benzofuran-2-yl)4-oxo buten-2-oique et/ou de ses sels pharmaceutiquement acceptables
FR2733911A1 (fr) Composition pharmaceutique pour maladies renales ou cardio-vasculaires
FR2576788A1 (fr) Compositions pharmaceutiques a base de 3-aminopropoxyindoles
JP2538422B2 (ja) 5―フルオロウラシル類により起こる炎症の発生を抑制する非注射剤形態の制癌剤